Olanzapine

Antipsychotics differed in their efficacy in preventing relapse hospitalization and treatment failure among patients with schizophrenia spectrum disorder, according to research published in JAMA Network Open.

Olanzapine reduced severe nausea more effectively than prochlorperazine for patients with refractory symptoms after chemotherapy, according to results of a randomized phase 3 trial.

Olanzapine significantly reduced nausea and vomiting compared with observation for patients with solid tumors undergoing moderately emetogenic chemotherapy, according to results of a randomized phase 3 trial.

SAN ANTONIO — Low-dose olanzapine appeared noninferior to the standard dose for controlling chemotherapy-induced nausea and vomiting without requiring delayed steroids among patients with solid tumors, according to study results.

Low-dose olanzapine significantly improved appetite and weight gain among patients with newly diagnosed cancer undergoing chemotherapy, according to study results published in Journal of Clinical Oncology.

Exposure to antipsychotics during pregnancy may not increase risk for birth defects, according to a study published in JAMA Psychiatry.

Alkermes announced positive topline results from its phase 3b study of Lybalvi in young adults with schizophrenia, schizophreniform disorder or bipolar I disorder who were early in their illness.

Alkermes has announced that its schizophrenia/bipolar 1 disorder treatment Lybalvi is now available by prescription in the U.S.

Researchers reported differences in antipsychotic treatment discontinuation among veterans with schizophrenia in an observational study published in American Journal of Psychiatry.

The FDA has approved an olanzapine/samidorphan combination treatment for schizophrenia and bipolar 1 disorder in adults.